Maurice Straetmans’ Post

Join our experts for a discussion on the intersection of MedTech, companion diagnostics, and regulatory compliance. Register for our upcoming webinar and gain insights that will empower your organization to navigate the evolving regulatory landscape. https://bit.ly/3xBQRap #CDx #IVDdevices

Iain's Industry Insights covering the latest Investments, Innovation and MedTech Insights. Some exciting investment stories that could unlock the potential of some fantastic innovation; a couple of FDA approvals for two MedTech goliaths and a couple of significant C-Suite changes. Links to all articles in the comments. Keep on making a difference! #medtech #insidemedtech #medicaltechnology #medicaldevices #industrynews

🔍 Million dollar question: where should you launch a new medical device or combination product first, in the EU or in the US? What are the current challenges in both areas? 🤔 If you wondered abou that, come meet us at the Swiss National Regulatory Conference, and let's discuss the best approach together. confinis will be engaging with peers and industry experts on the key regulatory challenges facing Europe today as part of Swiss Medtech. 🌍🩺 We’re excited to share insights and help you navigate these complex times. #innovators #regulatory #compliance #andbeyond #SwissRegulatoryConference #MedTech #RegulatoryStrategy #EUvsFDA

Check out some of the latest investment, innovation and industry insights from within the MedTech sector. From an oversubscribed Series A, to some of the largest corporates discussing their M&A strategy and some exciting FDA approvals. Oh, and a note that I will be attending Medica! Links to all articles in the comments. #medtech #insidemedtech #medtechnews #medtechninvestment

As every year, confinis is at the National Regulatory Conference in Bern. Some of you may remember that we had a very interesting panel discussion last year about the dramatic drop in startup fundraising in 2023 (-40%), and I think that what we all went through in the medtech and pharma industry over the last 12-18 months shows that it was not a simple VC problem, but rather a macroeconomical phase. Which we all hope will be over very soon. Unfortunately, this year we did not have the chance to follow up during the annual conference about the status of Swiss innovation, but we are organizing an event with Swiss Medtech for the end of the year that will takle this topic directly. We will come back to this soon. But let me use this occasion to give some previews: according to the Swiss VC Report 2024, investments further shrank by 10% with respect to 2023 figures. While early stage deals grew in number, companies raising Round B and beyond struggled to get capital. In my opinion, though, the worst sign that we should all reflect on is the very small number of exits for Swiss startups: 20 in a whole year, for the second year in a row. The outlook for next 12 months seems more positive than the past, but we must all work towards a thriving entrepreneurial environment - this is an identity that is essential to ensure long-term prosperity in Switzerland. Entrepreneurs need exits! #fundraising #innovation #startups #regulatoryaffairs #medicaldevices #deeptech #combinationproducts

I will attend the #MedTechSummit2024 next week, I am happy to connect with you and discuss your regulatory needs for medical devices and how Lumis International GmbH can support you. See you there! #MedTech #MedTechSummit2024 #RegulatoryServices #MedicalDevices #LumisInternational #LumisLifeScienceConsulting #MedicalDeviceRegulation #MDR

Launching a medical device in Europe can be challenging, especially when it comes to navigating the complex regulatory landscape. If this sounds familiar, you’re not alone! ▶️Check out the interview where I describe some regulatory hurdles medtech companies are expected to face in the upcoming months and we offer actionable strategies for overcoming them. Link: https://lnkd.in/eTGj-iYP We hope reading this interview helps you discover how to stay compliant with changing requirements and adopt a proactive and effective approach for success. #MedicalDevices #Medtech #RegulatoryAffairs #AliraHealth #MDR #IVDR

FDA inspections are nobody’s idea of a good time. However, proper planning can go a long way to not only ensuring baseline compliance, but also to establishing an effective corporate culture and building long-term company value. In this edition of Consultants Corner, we spotlight advice from Jamie Harris, MPH, RAC and Nancy Lince, RAC, who discussed the issue onstage last month at the MedTech Strategist Innovation Summit in Dublin: https://bit.ly/44EOS1y #medicaldevices #medtech #fda #InnovationDublin24

🚀 ESSENVIA RELEASE: WHEN MEDICAL DEVICE REGULATION MEETS MEDTECH INNOVATION, SPARKS CAN FLY. A manufacturer that is working to develop a novel disease-curing medical product could suddenly find itself behind the compliance 8 ball, spending unanticipated resources, including time and money. Regulatory professionals can avoid these problems and learn valuable solutions at a FREE blue-ribbon Essenvia panel webinar, “Shaping the Future of MedTech: Insights at the Crossroads of Regulation and Innovation.” ✅ When:  July 31, 2024 @ 2 PM EST ✅ Cost:  FREE ✅ Register:  https://lnkd.in/eFspvu4d 👉Check out the Essenvia Release below for more details, including info on our expert panelists. See you there! 💡Founded in 2018, Essenvia is a MedTech RIM platform that gives you the tools you need to manage regulatory workflows across the total product lifecycle, accelerate global market access, and generate exponential business value. Discover more about what Essenvia can do for your MedTech company at Essenvia.com. #Regulation #Innovation #Regulatory #MedTech #MedicalDevices #Webinars #Essenvia #RIM #RegulatoryManagement

Do you have the real picture on how GLP-1s are impacting your business? Join IQVIA MedTech on March 7 to learn how to plan with confidence for a successful MedTech future.